Form 4: SOPHIA GENETICS SA: Insider Sells Shares

SOPHIA GENETICS SA reports insider Muken Ross sold 3,687 ordinary shares on April 10, 2026, and 4,442 ordinary shares on April 13, 2026, as part of a pre-arranged trading plan.

Summary

• Muken Ross, an officer of SOPHiA GENETICS SA, sold a total of 8,129 ordinary shares across two transactions.
• The first sale occurred on April 10, 2026, involving 3,687 shares at a weighted average price of $4.6864.
• The second sale occurred on April 13, 2026, involving 4,442 shares at a weighted average price of $4.765.
• These sales were executed under a Rule 10b5-1(c) trading plan to cover tax withholding obligations related to vested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the insider sales are conducted under a pre-arranged plan to cover tax obligations, which is a standard and expected event for executives.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by the market.

Risks

• The sales were made to satisfy tax withholding obligations, which is a common and expected event for executives with vested equity awards.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.

Industry Context

StockSavvy.ai notes that insider selling, particularly when conducted under a pre-established Rule 10b5-1 plan to cover tax obligations, is a routine event for executives and often does not signal a negative view of the company's prospects. However, the volume and timing relative to other insider transactions can be a factor for market participants to consider.

Stakeholder Impact

• Shareholders: The sale of shares by an insider may lead to short-term market perception shifts, though the pre-planned nature for tax purposes mitigates significant negative impact.
• Employees: As the sales are for tax withholding related to vested RSUs, it reflects the compensation structure for executives.
• Management: The transaction is a standard part of executive compensation and compliance.

Key Dates

Keywords

SOPHIA GENETICS SA, SOPH, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Restricted Stock Units, Tax Withholding, Muken Ross